Momenta can't do anything about the rumor. The question is whether there is any reason to doubt the confidence that several people at Teva have expressed recently. A quote from r and d made to an Israeli paper-- "We are waiting to receive the approval soon and the chances of receiving it is high." I believe Teva has reason to think this is true.